Found: 18
Select item for more details and to access through your institution.
Comparison of Cilta-cel, an Anti-BCMA CAR-T Cell Therapy, Versus Conventional Treatment in Patients With Relapsed/Refractory Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 326, doi. 10.1016/j.clml.2021.10.013
- By:
- Publication type:
- Article
Safety and Efficacy of Ruxolitinib in Patients with Myelofibrosis and Low Platelet Counts (50 - 100 x 10<sup>9</sup>/L): Final Analysis of an Open-Label Phase 2 Study.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 336, doi. 10.1016/j.clml.2021.10.016
- By:
- Publication type:
- Article
POEMS Syndrome: Real World Experience in Diagnosis and Systemic Therapy - 108 Patients Multicenter Analysis.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 297, doi. 10.1016/j.clml.2021.10.007
- By:
- Publication type:
- Article
Disparity in Utilization of Multiagent Therapy for Acute Promyelocytic Leukemia in the United States.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 319, doi. 10.1016/j.clml.2021.10.010
- By:
- Publication type:
- Article
Antifungal Prophylaxis in AML Patients Receiving Intensive Induction Chemotherapy: A Prospective Observational Study From the Acute Leukaemia French Association (ALFA) Group.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 311, doi. 10.1016/j.clml.2021.10.011
- By:
- Publication type:
- Article
Infectious Complications Among Patients With AML Treated With Immune Checkpoint Inhibitors.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 305, doi. 10.1016/j.clml.2021.10.012
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Treatment of Older, Vulnerable Adults with Multiple Myeloma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 279, doi. 10.1016/j.clml.2021.11.003
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions: Pathology and Pathogenesis of Nodal Peripheral T-Cell Lymphomas.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. 287, doi. 10.1016/j.clml.2021.10.006
- By:
- Publication type:
- Article
State-of-the-Art Review on Myelofibrosis Therapies.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e350, doi. 10.1016/j.clml.2021.11.007
- By:
- Publication type:
- Article
Prognostic Role of "Radiological" Sarcopenia in Lymphoma: A Systematic Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e340, doi. 10.1016/j.clml.2021.11.006
- By:
- Publication type:
- Article
The AntiCD19 Antibody Drug Immunoconjugate Loncastuximab Achieves Responses in DLBCL Relapsing After AntiCD19 CAR-T Cell Therapy.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e335, doi. 10.1016/j.clml.2021.11.005
- By:
- Publication type:
- Article
Comparison of Outcomes After Second Allogeneic Hematopoietic Cell Transplantation Versus Donor Lymphocyte Infusion in Allogeneic Hematopoietic Cell Transplant Patients.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e327, doi. 10.1016/j.clml.2021.11.004
- By:
- Publication type:
- Article
COVID-19 Vaccine Responses in Patients With Plasma Cell Dyscrasias After Complete Vaccination.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e321, doi. 10.1016/j.clml.2021.11.001
- By:
- Publication type:
- Article
A New Reality for Multiple Myeloma Renal Failure: US Data Report on Kidney Transplant Outcomes.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e314, doi. 10.1016/j.clml.2021.11.002
- By:
- Publication type:
- Article
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma With Secondary Acquisition of t(11;14)(q13;q32)/CCND1-IGH: A Rare Variant Of Richter Transformation to Mantle Cell Lymphoma.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e310, doi. 10.1016/j.clml.2021.10.017
- By:
- Publication type:
- Article
Characteristics and Outcome of Extranodal NK/T-cell Lymphoma in North America: A Retrospective Multi-Institutional Experience.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e300, doi. 10.1016/j.clml.2021.10.018
- By:
- Publication type:
- Article
Excellent Prognosis of Low-Risk Myelodysplastic Syndromes (MDS) Without Detectable Myeloid-Related Mutations.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e293, doi. 10.1016/j.clml.2021.10.015
- By:
- Publication type:
- Article
Efficacy and Safety of Daratumumab-based Regimens in Pretreated Light Chain (AL) Amyloidosis: A Systematic Review.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 5, p. e285, doi. 10.1016/j.clml.2021.10.014
- By:
- Publication type:
- Article